NantHealth, Inc. Business Finance Contracts & Agreements
25 Contracts & Agreements
- Assignment Agreements (2 contracts)
- Credit Agreements (1)
- Exchange Agreements (2)
- Indenture Agreements (2)
- Note Agreements (11)
- Purchase Agreements (2)
- Registration Rights Agreements (2)
- Stock Agreements (1)
- Subordination Agreement (1)
- Underwriting Agreements (1)
- Stock Purchase Agreement, dated August 28, 2023, by and among the Company and the Purchasers (Filed With SEC on August 30, 2023)
- Subordination Agreement, dated March 2, 2023, by and between the Registrant, NaviNet, Inc., Airstrip Technologies, Inc. and Nant Capital, LLC (Filed With SEC on May 15, 2023)
- Credit Agreement, dated as of March 2, 2023, by and between the Registrant, certain subsidiaries of the Registrant, as the guarantors, the lender parties (Filed With SEC on May 15, 2023)
- Subordinated Promissory Note by and between the Company and (Filed With SEC on November 28, 2022)
- Subordinated Promissory Note by and between the Company and AirStrip Technologies, Inc. dated as of October 3, 2022 (Filed With SEC on October 6, 2022)
- Resale Registration Rights Agreement, dated April 27, 2021, by and among NantHealth, Inc. and certain buyers (Filed With SEC on April 28, 2021)
- Second Amended and Restated Promissory Note, dated April 27, 2021, by and between NantHealth, Inc. and Nant Capital LLC (Filed With SEC on April 28, 2021)
- Third Amended and Restated Promissory Note, dated April 27, 2021, by and between NantHealth, Inc. and Nant Capital LLC (Filed With SEC on April 28, 2021)
- Indenture, dated April 27, 2021, among NantHealth, Inc., NaviNet, Inc. and U.S. Bank National Association (Filed With SEC on April 28, 2021)
- Form of Exchange Agreement by and between the Company and (Filed With SEC on April 14, 2021)
- Form of Exchange Agreement by and between the Company and certain holders, dated as of April 1 (Filed With SEC on April 14, 2021)
- Amended and Restated Promissory Note by and between the Company and Nant Capital, LLC dated as of December 31, 2020 (Filed With SEC on January 5, 2021)
- Open NMS Assignment Agreement, dated as of July 22, 2020, between the Registrant and Cambridge Equities, LP (Filed With SEC on August 10, 2020)
- Asset Purchase Agreement dated as of January 13, 2020, among Masimo Corporation and VCCB Holdings, Inc., and NantHealth, Inc (Filed With SEC on February 28, 2020)
- Promissory note dated August 8, 2018, by the Company to the benefit of Nant Capital, LLC (Filed With SEC on August 9, 2018)
- Assignment Agreement, dated February 1, 2018, by and between the Company and NantOmics, LLC (Filed With SEC on May 10, 2018)
- SECOND AMENDED AND RESTATED PROMISSORY NOTE (Filed With SEC on December 21, 2016)
- PURCHASE AGREEMENT (Filed With SEC on December 21, 2016)
- NANTHEALTH, INC. 5.50%Convertible Senior Notes due 2021 Purchase Agreement (Filed With SEC on December 21, 2016)
- NANTHEALTH, INC. AND U.S. BANK NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of December 21, 2016 5.50% Convertible Senior Notes due 2021 TABLE OF CONTENTS (Filed With SEC on December 21, 2016)
- AMENDED AND RESTATED PROMISSORY NOTE (Filed With SEC on May 24, 2016)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on May 24, 2016)
- NANTHEALTH, INC. [ ] Shares of Common Stock, par value $0.0001 per share Underwriting Agreement (Filed With SEC on May 24, 2016)
- AMENDED AND RESTATED DEMAND PROMISSORY NOTE (Filed With SEC on May 11, 2016)
- AMENDED AND RESTATED PROMISSORY NOTE (Filed With SEC on May 11, 2016)